Association of pyrazinamide resistance in Mycobacterium tuberculosis with mutations in rpoB, katG, and inhA genes
Abstract Multidrug-resistant tuberculosis (MDR-TB) is associated with a high rate of treatment failure. Since the 9 to 11-month shorter oral regimen in MDR-TB treatment includes pyrazinamide (PZA), it is essential to assess the susceptibility of MDR-TB strains to PZA to guide effective therapy. The...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Portfolio
2026-05-01
|
| シリーズ: | Scientific Reports |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1038/s41598-026-53296-8 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|